Webster, Marie R <br/><br/>
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.  [electronic resource] 

 -  Molecular cell  02 2020 
 - 633-644.e5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-4164 
<br/><br/><label>Standard No.: </label>10.1016/j.molcel.2019.11.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--genetics<br/>Humans<br/>MAP Kinase Kinase Kinases--metabolism<br/>Melanoma--genetics<br/>Molecular Targeted Therapy<br/>Mutation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology<br/>Tumor Microenvironment--drug effects<br/>Tumor Suppressor Protein p53--genetics<br/>Wnt-5a Protein--metabolism